ALZHEIMER
Bibliografía
1. Graeber MB. No man alone: the rediscovery of Alois Alzheimer's
original cases. Brain Pathology 9, 237-240. 1999.
2. Lopez-Pousa S. Epidemiología de las demencias. In: Alberca R,
Lopez-Pousa S, editores. Enfermedad de Alzheimer y otras demencias. Madrid: 1998: 137-148.
3. Caballero Garcia JC. Demencia en España: situación actual y
prespectivas de futuro. Med Clin 1991; 97:431-436.
4. Boada M, Peña-Casanova J, Bermejo F, Guillen F, Hart WM,
Espinosa C et al. Coste de los recursos sanitarios de los pacientes en régimen
ambulatorio diagnosticados de enfermedad de Alzheimer en España. Med Clin 1999;
113:690-695.
5. Bermejo F, Colmenarejo C, Tejeiro J. Prevalence of dementia in
old people in four districts of Madrid: a pilot study. Neuroepidemiology 1993; 12:135.
6. Lopez-Pousa S, Vilalta J, Llinas J. Prevalence of dementia in the
general population: pilot study in Girona (Spain). Neuroepidemiology 2000; 10:99.
7. Jimenez-Escrig A, Blanco-Jerez CR, Orensanz L. Molecular Biology
and Genetics of Alzheimer's disease. Eur J Neurol 2, 465-476. 1995.
8. van Duijn C, Clayton DF, Chandra V. Familial aggregation of
Alzheimer's disease and related disorders: a collaborative reanalysis of case-control
studies. Int J Neuroepidemiol 20(suppl 2), S13-S20. 1991.
9. Emilien G, Maloteaux J-M, Beyreuther K, Master CL. Alzheimer
disease. Mouse models pave the way for therapeutic opportunities. Arch Neurol 2000;
57:176-181.
10. Markesbery WR. The role of oxidative stress in Alzheimer's
disease. Arch Neurol 1999; 56:1449-1452.
11. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's
disease: Implications for therapy. Am J Psychiatry 1994; 151:1105-1113.
12. Mackenzie IRA, Munoz DG. Nonsteroidal anti-inflammatory drug use
and Alzheimer-type pathology in aging. Neurology 1998; 50(4):986-990.
13. Marder K, Sano M. Estrogen to treat Alzheimer's disease: Too
little, too late? Neurology 54, 2035-2037. 2000.
14. Eisiri MM, Morris JH. Practical approach to pathological
diagnosis. En: Eisiri MM, Morris JH, editores. The neuropathology of dementia. Cambridge:
Cambridge University Press, 2000: 21-35.
15. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW,
Markesbery WR. "Preclinical" AD revisited. Neuropathology of cognitively normal
older adults. Neurology 2000; 55:370-376.
16. Morris JC. Clinical dementia rating (CDR): current verson and
scoring rules. Neurology 1993; 43:2412-2414.
17. Pollock BG, Mulsant H. Behavioral Disturbances of dementia. J
Geriatr Psychiatry Neurol 1998; 11:206-212.
18. Petersen RC. Mild cognitive impairment or questionable dementia.
Arch Neurol 57, 643-644. 2000.
19. Wahlund LO. Magnetic resonance imaging and computed tomography
in Alzheimer's disease. Acta Neurol Scand 1996; Suppl. 168:50-53.
20. Ryding E. SPECT measurements of brain function in dementia: a
review. Acta Neurol Scand 1996; Suppl 168:54-58.
21. Spreen O, Strauss E. A compendium of neuropsychological test.
Administration, norms and commentary. New York: Oxford University Press, 1998.
22. Emilien G, Beyreuther K, Colin LM, Maloteaux J-M. Prospects for
pharmacological intervention in Alzheimer disease. Arch Neurol 57, 454-459. 2000. )
23. Mayeux R, Sano M. Treatment of Alzheimer's disease. N Engl J Med
341, 1670-1679. 2000.
24. Salzman C. Treatment agitation in the elderly. In: Meltzer YH,
editor. Psychopharmacology. New York: Raven Press, 1987.
25. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T et al.
Immunization with amyloid-b attenuates Alzheimer-disease-like pathology in the PDAPP
mouse. Nature 1999; 400:173-177.
Bibliografìa bàsica recomendada
Alberca, R and Bermejo, F. Del envejecimiento
a la enfermedad de Alzheimer. Continua Neurologica 1. 1998. Masson.
Alberca R, Lopez-Pousa, S. Enfermedad de Alzheimer y otras
demencias. Madrid: IM&C, 1998.
Bermejo F, Rivera J, Trincado R, Olanzaran J, Morales JM. Aspectos
sociales y familiares del paciente con demencia. Madrid: Diaz de Santos, 1998.
Cummings JL. Current perspectives in Alzheimer's disease. Neurology.
1998; 51: S1.
Gasparini L, Racchi M, Binetti G et al. Peripheral markers in
testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB.J. 1998;
12: 17-34.
Grupo de estudio de Neurología de la Conducta y Demencias de la
Sociedad Española de Neurología. Guía de demencias. Conceptos, criterios y
recomendaciones para el estudio de la demencia. Barcelona: Masson, 2000.
L. H. Heston. Avances en la Enfermedad de Alzheimer y estados
similares. Barcelona: J&CS.L, 1998.
Pascual Millán, L. F. Semiología y especificidad en el
diagnóstico clínico de la enfermedad de Alzheimer. Drug Update. Drug Pharma , 1997.
Terry RD, Katzman, R, Bick KL. Alzheimer Disease. New York: Raven
Press, 1994.
Villareal DT, Morris CJ. The diagnosis of Alzheimer's disease.
Alzheimer's Dis Rev 3: 142-152, 2000
| Sumario
|
